NeoGenomics to participate in Morgan Stanley Global Healthcare conference
NeoGenomics, Inc. (NEO) said it will participate in the Morgan Stanley 24th Annual Global Healthcare Conference Sept. 14–16, 2026 in New York, NY.
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that the Company will participate in the Morgan Stanley 24th Annual Global Healthcare Conference, which is being held Sept.
14—16, 2026, in New York, NY.Management’s…